Co. Drills To Expand Resource at Ni-PGE Project in U.S.
Co. Drills To Expand Resource at Ni-PGE Project in U.S.
Source: investorideas.com
📰 Program Updates News
Page 11 - Program Updates News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Program Updates. Real-time updates on events, politics, business and more.
Inverness to decide final millage rate, budget
Inverness City Council members will be setting the final millage rate and budget adoption for Fiscal Year 2023-24 when it convenes at 5:30 p.m. Tuesday, Sept. 19.
Sunrise Group Lobbyist Agreement Program Updates Public Art Initiative Mural Artist Selection Inverness City Council Fiscal Year Citrus County Chronicle
Source: chronicleonline.com
Silence Therapeutics Reports Second Quarter 2023 Results
Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines,... -Today at 07:03 am- MarketScreener
Craig Tooman Hansoh Pharma Program Updates Mallinckrodt Pharmaceuticals Exchange Commission On Silence Therapeutics
Source: marketscreener.com
Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update
NDA submission for etripamil in patients with PSVT expected in October 2023Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with... -Today at 07:37 am- MarketScreener
Source: marketscreener.com
Veru Reports Fiscal 2023 Third Quarter Financial Results
Company receives further regulatory clarity from FDA on Phase 3 ENABLAR-2 study. Potential for enobosarm +/- abemaciclib accelerated approval pathway in metastatic breast cancer, if successful based... -Today at 06:31 am- MarketScreener
Source: marketscreener.com
Candel Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
NEEDHAM, Mass., Aug. 10, 2023 -- Candel Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients fight cancer, today reported... -Today at 08:02 am- MarketScreener
United States Sylvia Wheeler Aljanae Reynolds Cancer Foundation Company Nasdaq American Society Of Clinical Oncology
Source: marketscreener.com
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
CRB-701 Phase 1 trial in China is ahead of schedule with dose escalation completion expected Q4 2023 and U.S. clinical trial start planned for Q1 ...
Source: businessinsider.com
Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates
/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...
Source: prnewswire.com
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
NDA submitted to US FDA for ensifentrine for maintenance treatment of COPD Phase 3 ENHANCE data published in the American Journal of Respiratory and Critical Care Medicine Strong balance sheet to...
Source: marketscreener.com
Xencor Reports Second Quarter 2023 Financial Results
-- Management to Host Conference Call at 4:30 p.m. ET Today -- ...
Bassil Dahiyat Xencor Xmab Congress On European Society For Medical Oncology European Congress Program Updates
Source: marketscreener.com